Trifocal diffractive IOLs provide significantly better intermediate vision over bifocal IOLs, with equivalent postoperative levels of visual and ocular optical quality.

The authors have no proprietary or commercial interest in the medical devices that are involved in this manuscript.

No author has a financial or proprietary interest in any material or method mentioned.

Bifocal and trifocal diffractive IOLs are able to provide an effective visual restoration which is maintained during a 12-month follow-up, with a clear benefit of the trifocal IOL for the intermediate vision.